Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha in human rheumatoid arthritis fibroblast-like synoviocyte
Rheumatology International, 10/30/09
He Y et al. – Increasing evidence indicates that the anti-malarial agent artemisinin and its derivatives may exert anti-angiogenic effect. In the present study, we explored the effect of artesunate, a artemisinin derivative, on TNF?- and hypoxia-induced expression of hypoxia inducible factor-1? (HIF-1?) and secretion of vascular endothelial growth factor (VEGF) and inteleukin-8 (IL-8) in human rheumatoid arthritis fibroblast-like synoviocytes (RA FLS), and further investigated the signal mechanism by which this compound modulates HIF-1?, VEGF and IL-8 expression.
Methods- RA FLS obtained from patients with active RA were pretreated with artesunate, and then stimulated with TNF &alpha and hypoxia
- Production of VEGF and IL-8 measured by ELISA
- Nuclear location of HIF-1 &alpha measured by confocal fluorescence microscopy
- HIF-1 &alpha and other signal transduction proteins expression was measured by Western blot
- Artesunate decreased secretion of VEGF and IL-8 from TNF &alpha- or hypoxia-stimulated RA FLS in dose-dependent manner
- Artesunate prevented Akt phosphorylation, but did not find evidence that phosphorylation of p38 and ERK was affected
- TNF &alpha- or hypoxia-induced secretion of VEGF and IL-8 and expression of HIF-1 &alpha hampered by treatment with PI3 kinase inhibitor LY294002, suggesting that inhibition of PI3 kinase/Akt activation might inhibit VEGF and IL-8 secretion and HIF-1 &alpha expression induced by TNF &alpha or hypoxia
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: A cohort study
Annals of Rheumatic Diseases, 03/21/10
A review of the effect of anticonvulsant medications on bone mineral density and fracture risk
The American Journal of Geriatric Pharmacotherapy, 03/19/10
Severe exfoliative dermatitis caused by strontium ranelate: two cases of a new drug reaction
Age and Aging, 03/19/10
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases
Journal of Rheumatology, 03/21/10
Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk
Annals of Rheumatic Diseases, 03/21/10
Biomarkers in early rheumatoid arthritis: Longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs
Annals of Rheumatic Diseases, 03/21/10
Article Search
Sponsor
Sponsor


See Latest Articles


